Prosecution Insights
Last updated: October 25, 2026

Nextbiomedical Co. Ltd.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Nextbiomedical Co. Ltd. currently manages 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This specific workload is concentrated under 1 distinct examiner and 1 distinct art unit. The focus of current prosecution activity rests entirely with examiner NORTH, ISABELLA SARAH HYO SO, who is responsible for the 1 busiest examiner pending office action.

For a practitioner, this centralized portfolio structure means that prosecution outcomes are currently dependent on the assigned personnel at the USPTO. With 1 distinct examiner involved, the applicant lacks the diversity of examiner perspectives that larger portfolios often encounter. The presence of 1 distinct art unit suggests a narrow technological focus for the pending matters within this sector.

The active workload assigned to NORTH, ISABELLA SARAH HYO SO represents the total current engagement with the office. Monitoring the specific tendencies and past allowance rates of this individual is critical, as there are no other pending actions to balance potential difficulties. This arrangement defines the current landscape for Nextbiomedical Co. Ltd.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NORTH, ISABELLA SARAH HYO SO 1 63.6% +15.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18242640 DISPENSER DEVICE FOR SPRAYING POWDER NORTH, ISABELLA SARAH HYO SO —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18242640 DISPENSER DEVICE FOR SPRAYING POWDER NORTH, ISABELLA SARAH HYO SO —

Top Art Units

Art UnitApps
3783 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18242640 DISPENSER DEVICE FOR SPRAYING POWDER NORTH, ISABELLA SARAH HYO SO 3783 §102§103§112 Non-Final OA — Pending Sep 06, 2023

Managing Nextbiomedical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Nextbiomedical Co. Ltd. have?

Nextbiomedical Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Nextbiomedical Co. Ltd. applications?

Isabella Sarah Hyo So North has the most, with 1 of Nextbiomedical Co. Ltd.'s pending office actions.

What technology area are Nextbiomedical Co. Ltd.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month